Clinical and radiographic predictors of cardiovascular implantable electronic device lead failure at the time of initial implantation [0.03%]
初始植入时心血管植入式电子装置导线故障的临床和放射预测因素
Eun-Jeong Kim,Giovanni Davogustto,Shi Huang et al.
Eun-Jeong Kim et al.
Objective: To assess the clinical and radiographic factors associated with lead failure by comparing subjects with lead failure within 10 years of implantation with an implant-year-matched group without lead failure. ...
Cost-effectiveness of insertable cardiac monitors for diagnosis of atrial fibrillation in cryptogenic stroke in Australia [0.03%]
澳大利亚在隐源性卒中患者中心脏监测仪诊断房颤的成本效益
Vincent Thijs,Klaus K Witte,Carmel Guarnieri et al.
Vincent Thijs et al.
Introduction: Detection of atrial fibrillation (AF) is required to initiate oral anticoagulation (OAC) after cryptogenic stroke (CS). However, paroxysmal AF can be difficult to diagnose with short term cardiac monitoring....
Analysis of the determining factors of detectable P-wave and amplitude of QRS complex sensed by implantable loop recorder [0.03%]
植入式心电事件监测器感知P波及QRS波振幅的影响因素分析
Jang Ho Ahn,Hyunho Ryu,Il-Young Oh et al.
Jang Ho Ahn et al.
Background: Determining factors for sufficient QRS amplitude and discernible P-wave sensing in implantable loop recorder (ILR) are unknown. We aimed to investigate determining factors and ILR implantation angle that may i...
Factors affecting signal quality in implantable cardiac monitors with long sensing vector [0.03%]
长感知向量植入式心脏监测器的信号质量影响因素分析
Giovanni B Forleo,Claudia Amellone,Riccardo Sacchi et al.
Giovanni B Forleo et al.
Purpose: Electrical artefacts are frequent in implantable cardiac monitors (ICMs). We analyzed the subcutaneous electrogram (sECG) provided by an ICM with a long sensing vector and factors potentially affecting its qualit...
RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy [0.03%]
室性心动过速的评估及植入型心律转复除颤器治疗的效果中的RR间期变异性的评估及植入型心律转复除颤器治疗的效果中的rr间距变异
Keita Tsukahara,Yasushi Oginosawa,Yoshihisa Fujino et al.
Keita Tsukahara et al.
Background: An implantable cardioverter defibrillator (ICD) is the most reliable therapeutic device for preventing sudden cardiac death in patients with sustained ventricular tachycardia (VT). Regarding its effectiveness,...
Selvester score predicts implantable cardioverter defibrillator shocks in patients with non-ischemic cardiomyopathy [0.03%]
塞尔夫斯特评分能预测非缺血性心肌病患者植入型心脏除颤器的放电次数
Fazıl Arısoy,Ozlem Ozcan Celebi,İlke Erbay et al.
Fazıl Arısoy et al.
Background: The implantable cardiac defibrillator is the cornerstone of prevention of sudden cardiac death in non-ischemic cardiomyopathy. The Selvester score, which is frequently investigated in ischemic cardiomyopathy, ...
Anti-tachycardia pacing for non-fast and fast ventricular tachycardias in individual Japanese patients: From Nippon-storm study [0.03%]
日本 nippon-storm 研究者对单个患者的非室上速和室上速的抗心动过速起搏疗法：日本 nippon-storm 研究
Masaomi Chinushi,Osamu Saitoh,Hiroshi Furushima et al.
Masaomi Chinushi et al.
Background: Anti-tachycardia pacing (ATP) delivered from an implantable device is a useful tool to terminate ventricular tachycardia (VT). But its real-world efficacy for those patients having multiple VTs with varying VT...
Rationale and design of the HINODE study: Heart failure indication and sudden cardiac death prevention trial Japan [0.03%]
HINODE研究的目的和设计：日本心力衰竭适应症和突发性心脏死亡预防试验
Hiro Yamasaki,Kenji Ando,Takanori Ikeda et al.
Hiro Yamasaki et al.
Background: Randomized trials in Western countries have provided evidence that prophylactic implantable cardioverter-defibrillator (ICD) therapy reduces mortality in heart failure (HF) patients with reduced left ventricul...
Ambulatory ECG monitoring for syncope and collapse in United States, Europe, and Japan: The patients' viewpoint [0.03%]
美国、欧洲和日本的直立性低血压患者对动态心电监护的态度调查结果摘要
Meltem Altinsoy,Richard Sutton,Ritsuko Kohno et al.
Meltem Altinsoy et al.
Background: Practice guidelines provide clinicians direction for the selection of ambulatory ECG (AECG) monitors in the evaluation of syncope/collapse. However, whether patients' understand differences among AECG systems ...
Effect of ranolazine on Tp-e interval, Tp-e/QTc, and P-wave dispersion in patients with stable coronary artery disease [0.03%]
Ranolazine对稳定型冠心病患者Tp-e间期、Tp-e/QTc及P波离散度的影响
Murat Akcay,Metin Coksevim,Mustafa Yenercag
Murat Akcay
Introduction: Ranolazine is an antianginal drug and also exhibits antiarrhythmic effect by affecting action potential time, refractory period, and repolarization reserve. We evaluated the effect of ranolazine therapy on m...